Dos & Dont’s
Hep C Is Manageable—If You Know the Ins and Outs
by Larry Buhl
You’ve been diagnosed with Hepatitis C. Now what? First, don’t panic. Doctors agree...
Going Viral
While federal efforts move forward, hepatitis prevention remains unfunded
by Larry Buhl
During the seemingly interminable debate over health insurance reform, other health legislation was quietly...
Fat Chance
A Treatment for Lipodystrophy-Related Excessive Abdominal Fat Comes of Age
by Chael Needle
HIV-associated lipodystrophy, abnormalities in metabolism and/or distribution of fat in those living with...
Be Smart
In an Effort to Prevent HCV, One Campaign Is Educating Youth on Body Art Risks
by Larry Buhl
In the U.S., an estimated thirty-six percent of...
Borrowing Therapies
Two Anti-Cancer Drugs Are Tapped in the Fight Against HIV
by Chael Needle
New types of drugs are needed in the fight against HIV but some of...
Clearing Hurdles
What can we do to address the obstacles to HCV treatment?
by Larry Buhl
Hepatitis C (HCV) is a “silent killer” in more ways than one....
REALIZE Gets Real
Hep Talk
Hepatitis C Antiviral Telaprevir Moves Closer to Approval
by Larry Buhl
Researchers in a recent Phase III study are encouraged by the results of a...
Gut Instinct
AIDS Healthcare Foundation Trains a Research Lens on Probiotics
by Chael Needle
"Probiotics” has become a new buzz word in the dairy aisle—at least two brands...
Revisiting Immunity
NAPWA helps to promote immune-based therapies
by Chael Needle
At the International AIDS Conference last June, the AIDS Institute and the National Association of People with AIDS...
LATEST POSTS
Ron B: Cover Story
“You had me at Angels in America,” I tell Ron B. when I see her at the Manhattan Neighborhood Network studios, in New York...
